PMC2705154_01
Before and after radiotherapy
cln64_6p599f1.jpg
PMC2705154_01_cln64_6p599f1.jpg
f1-cln64_6p599
She had a complete response with clearing of the neoplasm (Figure 1).
Before and after radiotherapy
cln64_6p599f2.jpg
PMC2705154_01_cln64_6p599f2.jpg
f2-cln64_6p599
She also had a complete response; however, after 3 months, there was a recurrence of the neoplasm (Figure 2).
Before and after PDT
cln64_6p599f3.jpg
PMC2705154_01_cln64_6p599f3.jpg
f3-cln64_6p599
Patient 5 showed no clinical or histopathological signs of the disease, with hypocromic residual macula (Figure 3).
Before and after treatment with PDT
cln64_6p599f4.jpg
PMC2705154_01_cln64_6p599f4.jpg
f4-cln64_6p599
Patients 6 and 7 still had clinical and histopathological neoplasia; nevertheless, they had 40-60% reductions in their lesions and great improvement in the comfort level and quality of life (Figures 4 and 5).
Before and after treatment with PDT
cln64_6p599f5.jpg
PMC2705154_01_cln64_6p599f5.jpg
f5-cln64_6p599
Patients 6 and 7 still had clinical and histopathological neoplasia; nevertheless, they had 40-60% reductions in their lesions and great improvement in the comfort level and quality of life (Figures 4 and 5).